Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Friday, July 31, 2020
Impact Biomedical initiates Quantum, a new frontier in Pharmaceutical Development
Wednesday, June 24, 2020
Impact Biomedical Achieves COVID-19 Success with Equivir and 3F Biofragrance
Wednesday, June 17, 2020
Impact Biomedical Announces Publication of COVID-19 Research in Peer-Reviewed Journal
Monday, June 1, 2020
Impact Biomedical and GRDG Sciences Announce Medical Technology Package Valued at USD 1.39 Billion (SGD 1.97 Billion) by Independent Experts
Friday, April 24, 2020
Impact Biomedical's Majority Owned Next Generation Medical Technologies Valued at USD 592 Million (SGD 841 Million) by Independent Experts
Wednesday, March 18, 2020
Impact BioMedical's Linebacker and Equivir inhibit SARS-CoV-2, virus responsible for the COVID-19 outbreak
Friday, November 15, 2019
Global BioLife to Present 3F Antimicrobial Fragrance at 2020 ASM Biothreats
Tuesday, October 29, 2019
Global BioLife to present Functional Fragrance Formula at the American Society for Microbiology's Biothreats Conference as a New Method to Prevent and Treat Tuberculosis
Wednesday, July 24, 2019
Global BioLife unveils naturally modified Laetose at Harvard Global Catalyst Health Summit
Wednesday, June 12, 2019
Global BioLife's 3F Mosquito Repellent Formula performs well in Independent Testing

Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6859 8575

Connect With us: